Enable JavaScript to ensure website accessibility
Precipio Announces 213% Year-Over-Year Revenue Growth In Preliminary Q2-2018 Results

Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, CT, (July 18th, 2018) – Specialty [...]

Precipio And Nucleai Partner To Develop Artificial Intelligence-Powered Hemepath Solution

System will support Hematopathologists in accurately identifying abnormalities to ensure diagnostic accuracy NEW HAVEN, CT, [...]

Precipio Updates Commercial Pipeline For Its ICE-COLD PCR™ Liquid Biopsy Technology

Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, CT, (June 19th, [...]

Precipio Inc. Announces Adjournment Of Annual Meeting Of Shareholders

NEW HAVEN, CT, (June 15th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that [...]

Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018

NEW HAVEN, CT, (June 14th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]

Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018

NEW HAVEN, CT, (June 12th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]

Precipio Strengthens Patent Portfolio With Expanded Reagent Claims For Its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, CT, (June 06th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the [...]

Precipio Launches Liquid Biopsy DNA Enrichment Sales In Europe With First Order

$10 million annual Europe market anticipated with $1 million annual addressable sales potential from local [...]

Potential Sequential Revenue Run-Rate Growth Of 30% Over Q1, Based On Preliminary April Results

Revenue growth accelerating as new sales initiatives and expanded team gain traction NEW HAVEN, CT, [...]

Precipio Launches ICE COLD-PCR™ Liquid Biopsy Reagent For Pancreatic Cancer

Ultra-sensitive enrichment reagent enables development of low cost detection tests, allowing optimized patient treatment NEW [...]